| Fact Sheets (10)

Learn more about our 3D structural cardiotoxicity assay including:

Learn more about the Cardiotox Screen for assessment of structural and functional cardiotoxicity including:

DOWNLOAD

Learn more about Human iPSC-Derived Mixed CNS Cells and their advantages including:

DOWNLOAD

Learn more about the advantages of human iPSC-derived cardiomyocytes including:

Predictive and physiological cell model
Applicable for drug development, preclinical research, and cardiac safety assessment
Quantity, consistency and efficiency for HTS

DOWNLOAD

Learn more about in Vitro iPSC research services at Evotec including:

Robust differentiation protocols or adaptation of client protocols
High-quality production of iPSC-derived cells at large scale
Disease-relevant phenotypic read-outs for exploratory research and compound profiling/HTS
Proprietary iPSC patent portfolio in tissue and disease modeling

DOWNLOAD

Learn more about inhalation drug development at Evotec including:

Integrated and stand-alone development plans tailored to your project
Formulation development of dry powders and liquids designed to meet a quality target product profile (QTPP) with consideration of final commercial process
Inhaled analytics, API, material science, cGMP maufacturing and quality assurance processes

Learn more about Evotec's long term vision in Kidney Disease therapeutics including:

Download this fact sheet to learn more about innovative technologies that dramatically expand global access to biotherapeutics including:

Machine learning derived human repertoire
Proprietary suite of predictive computational tools
Disposable technologies and intensified processes creating flexible, deployable and cost-effective manufacturing

Download

Download this fact sheet to learn more about Huntington's Disease proteome base including:

DOWNLOAD

Download this fact sheet to learn more about Huntingtin quantitation assays including:

DOWNLOAD

Science Pool